Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Balversais an anti-tumor drug for FGFR mutant tumors, which is usually administe···【more】
Release date：2024-08-27Recommended：212
Balversa is an innovative targeted therapy drug that is clinically used in patie···【more】
Release date：2024-08-27Recommended：216
Stipentol is an anti-epileptic drug that reduces seizures primarily by boosting ···【more】
Release date：2024-08-27Recommended：201
Alpelisib is the drug of choice for patients with PIK3CA-mutated breast cancer a···【more】
Release date：2024-08-27Recommended：216
In 2022, Alpelisib received accelerated FDA approval for patients on the PIK3CA-···【more】
Release date：2024-08-27Recommended：196
As the first oral small molecule drug for HR/HER2- and PIK3CA-mutated advanced b···【more】
Release date：2024-08-27Recommended：202
In 2022, Alpelisib received accelerated FDA approval for the treatment of adults···【more】
Release date：2024-08-27Recommended：189
Balversa is currently a new star in the field of anti-cancer, which is used oral···【more】
Release date：2024-08-27Recommended：192
Alpelisib was approved by the FDA in 2019 as a PIK3CA kinase inhibitor in combin···【more】
Release date：2024-08-27Recommended：205
Balversa is a new oral anti-cancer star on the market, showing excellent tumor s···【more】
Release date：2024-08-27Recommended：191
Alpelisib was approved by the FDA in May 2019 for use in combination with fulves···【more】
Release date：2024-08-27Recommended：221
As a PIK3CA kinase inhibitor, Alpelisib plays an important role in the relations···【more】
Release date：2024-08-27Recommended：223
